Table 2 Clinical characteristics of high and low Ascore groups in Gulou-Cohort1
Characteristic | No (%) | P value | |
|---|---|---|---|
Ascore-High (N = 31) | Ascore-Low (N = 31) |  | |
Age | |||
  < 65 | 6 (9.7%) | 14 (22.6%) |  |
  >  = 65 | 26 (41.9%) | 16 (25.8%) | 0.029 * |
Gender | |||
 Female | 11 (17.7%) | 14 (22.6%) |  |
 Male | 21 (33.9%) | 16 (25.8%) | 0.438 |
Stage | |||
 Stage II | 12 (19.4%) | 22 (35.5%) |  |
 Stage III | 20 (32.3%) | 8 (12.9%) | 0.006 ** |
T stage | |||
 T2 | 14 (22.6%) | 23 (37.1%) |  |
 T3 | 18 (29%) | 7 (11.3%) | 0.011 * |
Lymph node metastasis | |||
 No | 23 (37.1%) | 28 (45.2%) |  |
 Yes | 9 (14.5%) | 2 (3.2%) | 0.044 * |
ECOG score | |||
 0 | 22 (35.5%) | 25 (40.3%) |  |
 1 | 9 (14.5%) | 6 (9.7%) | 0.554 |